LICENSE AGREEMENTLicense Agreement • October 11th, 2011 • Puma Biotechnology, Inc. • Blank checks • New York
THIS LICENSE AGREEMENT (“Agreement”) is entered into as of the 18th day of August, 2011 (the “Execution Date”), by and between Puma Biotechnology, Inc., a corporation organized and existing under the laws of Delaware with offices at 10940 Wilshire Blvd, Suite 600, Los Angeles, CA 90024 (“LICENSEE”) and Pfizer Inc., a corporation organized and existing under the laws of Delaware with offices at 235 East 42nd Street, New York, NY 10017 (“PFIZER”), on its own behalf and on behalf of its Affiliates. LICENSEE and PFIZER may, from time-to-time, be individually referred to as a “Party” and collectively referred to as the “Parties”.
PUMA BIOTECHNOLOGY, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 11th, 2011 • Puma Biotechnology, Inc. • Blank checks • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of October 4, 2011, by and among Puma Biotechnology, Inc., a Delaware corporation (the “Company”), each person listed on Exhibit A attached hereto (collectively, the “Investors” and each individually, an “Investor”), and Innovative Acquisitions Corp., a Delaware corporation (“IAC”), but only for purposes of assuming all of the Company’s rights, duties and obligations hereunder pursuant to Section 8. Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in Section 9(q) herein.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 11th, 2011 • Puma Biotechnology, Inc. • Blank checks • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated this 4th day of October, 2011, is entered into by and among Puma Biotechnology, Inc., a Delaware corporation (the “Corporation”), the persons listed on Schedule I attached hereto (the “Investors,” and each individually, an “Investor”), and Innovative Acquisitions Corp., a Delaware corporation (“IAC”), but only for purposes of assuming all of the Corporation’s rights, duties and obligations hereunder pursuant to Section 11.
PUMA BIOTECHNOLOGY, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCKWarrant Agreement • October 11th, 2011 • Puma Biotechnology, Inc. • Blank checks • New York
THIS CERTIFIES THAT, for value received, [INVESTOR], with its principal address at [ ], or its assigns (the “Holder”), is entitled to subscribe for and purchase from PUMA BIOTECHNOLOGY, INC., a Delaware corporation (the “Company”), the Warrant Shares (as defined below) at a price per share equal to the Exercise Price, on the terms and subject to the conditions contained herein only if a Triggering Event occurs. This warrant (this “Warrant”) is one of a series of warrants of like tenor originally issued by the Company pursuant to that certain Securities Purchase Agreement, dated October 4, 2011, by and among the Company and the persons listed on Schedule I attached thereto (the “Purchase Agreement”).
PUMA BIOTECHNOLOGY, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCKWarrant Agreement • October 11th, 2011 • Puma Biotechnology, Inc. • Blank checks • New York
This warrant (this “Warrant”) is being issued pursuant to that certain Securities Purchase Agreement, dated October 4, 2011, by and among the Company and the persons listed on Schedule I attached thereto (the “Purchase Agreement”).
REDEMPTION AGREEMENTRedemption Agreement • October 11th, 2011 • Puma Biotechnology, Inc. • Blank checks • New York
This Agreement (the “Agreement”) is made as of October 4, 2011, by and among Innovative Acquisitions Corp., a Delaware corporation (the “Issuer”), and the stockholders of the Issuer listed on Schedule A attached hereto (each individually, a “Seller” and collectively, the “Sellers”).
